Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis
Purpose Low skeletal muscle mass has been associated with poor prognosis in patients with advanced lung cancer. However, little is known about the relationship between skeletal muscle mass and overall survival in patients with bone metastases from lung cancer. The objective of the present study was...
Gespeichert in:
| Veröffentlicht in: | Supportive care in cancer 2020, Vol.28 (1), p.389-394 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 394 |
|---|---|
| container_issue | 1 |
| container_start_page | 389 |
| container_title | Supportive care in cancer |
| container_volume | 28 |
| creator | Dohzono, Sho Sasaoka, Ryuichi Takamatsu, Kiyohito Hoshino, Masatoshi Nakamura, Hiroaki |
| description | Purpose
Low skeletal muscle mass has been associated with poor prognosis in patients with advanced lung cancer. However, little is known about the relationship between skeletal muscle mass and overall survival in patients with bone metastases from lung cancer. The objective of the present study was to evaluate the prognostic value of low trunk muscle mass in predicting overall survival in these patients.
Methods
The data from 198 patients who were diagnosed with bone metastases from lung cancer from April 2009 to May 2017 were retrospectively reviewed. The areas of the psoas and paravertebral muscles were measured at the level of the third lumbar vertebra on computed tomography scans taken at the time nearest to the diagnosis of bone metastasis. Muscle area was evaluated for male and female cohorts separately using different cutoff points. Cox proportional hazards analysis was performed to evaluate the factors independently associated with overall survival.
Results
The overall survival of patients in the lowest quartile for psoas muscle area or paravertebral muscle area was significantly shorter than that of patients above the 25th percentile for muscle area (
p
|
| doi_str_mv | 10.1007/s00520-019-04843-9 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2232107010</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A606998516</galeid><sourcerecordid>A606998516</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-8b0caf46661826624190bed7c3996dd41b1e431f68837ebb0ccd6c95bef952ff3</originalsourceid><addsrcrecordid>eNp9kU9rFTEUxYMo9ln9Ai4k4MbN1Js_k5ksS9EqPHCj65DJ3DxTZpLXZMbSb2_qtBZFJIFA7u-ce5NDyGsGZwyge18AWg4NMN2A7KVo9BOyY1KIphNCPyU70JI1UrTtCXlRyhUA67qWPycngkHbKqV25HqfbujRZvsD84JDthOd1-ImpLMthYZYi0vAuBR6E5bvdEixlnCxpW4s1Oc002mNB-psdJhpKLQKkwt2wXHTHFPK9JjTIaYSykvyzNup4Kv785R8-_jh68WnZv_l8vPF-b5xUvKl6Qdw1ss6JOu5UlwyDQOOnRNaq3GUbGAoBfOq70WHQ6XdqJxuB_S65d6LU_Ju862dr1csi5lDcThNNmJai-FccAYdMKjo27_Qq7TmWKerFNM9F1KLR-pgJzQh-rRk6-5MzbkCpXXfMlWps39QdY04B1d_z4d6_4eAbwKXUykZvTnmMNt8axiYu5zNlrOpOZtfORtdRW_uJ16HGcffkodgKyA2oNRSPGB-fNJ_bH8CUcuyrg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2219823493</pqid></control><display><type>article</type><title>Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Dohzono, Sho ; Sasaoka, Ryuichi ; Takamatsu, Kiyohito ; Hoshino, Masatoshi ; Nakamura, Hiroaki</creator><creatorcontrib>Dohzono, Sho ; Sasaoka, Ryuichi ; Takamatsu, Kiyohito ; Hoshino, Masatoshi ; Nakamura, Hiroaki</creatorcontrib><description>Purpose
Low skeletal muscle mass has been associated with poor prognosis in patients with advanced lung cancer. However, little is known about the relationship between skeletal muscle mass and overall survival in patients with bone metastases from lung cancer. The objective of the present study was to evaluate the prognostic value of low trunk muscle mass in predicting overall survival in these patients.
Methods
The data from 198 patients who were diagnosed with bone metastases from lung cancer from April 2009 to May 2017 were retrospectively reviewed. The areas of the psoas and paravertebral muscles were measured at the level of the third lumbar vertebra on computed tomography scans taken at the time nearest to the diagnosis of bone metastasis. Muscle area was evaluated for male and female cohorts separately using different cutoff points. Cox proportional hazards analysis was performed to evaluate the factors independently associated with overall survival.
Results
The overall survival of patients in the lowest quartile for psoas muscle area or paravertebral muscle area was significantly shorter than that of patients above the 25th percentile for muscle area (
p
< 0.001). Multivariate analyses showed that paravertebral muscle mass (hazard ratio, 1.73; 95% confidence interval, 1.17–2.56;
p
= 0.006), epidermal growth factor receptor-targeted therapy, and performance status were independent prognostic factors.
Conclusions
Low paravertebral muscle mass was associated with shorter survival, independently of known prognostic factors.</description><identifier>ISSN: 0941-4355</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-019-04843-9</identifier><identifier>PMID: 31055666</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Bone cancer ; Bone Neoplasms - diagnosis ; Bone Neoplasms - mortality ; Bone Neoplasms - secondary ; Cancer ; Cancer patients ; Carcinoma, Non-Small-Cell Lung - diagnosis ; Carcinoma, Non-Small-Cell Lung - mortality ; Carcinoma, Non-Small-Cell Lung - pathology ; CT imaging ; Female ; Health aspects ; Humans ; Lumbar Vertebrae - diagnostic imaging ; Lumbar Vertebrae - pathology ; Lung cancer ; Lung Neoplasms - diagnosis ; Lung Neoplasms - mortality ; Lung Neoplasms - pathology ; Male ; Medical prognosis ; Medicine ; Medicine & Public Health ; Metastasis ; Middle Aged ; Muscle, Skeletal - diagnostic imaging ; Muscle, Skeletal - pathology ; Muscles ; Musculoskeletal system ; Nursing ; Nursing Research ; Oncology ; Oncology, Experimental ; Original Article ; Pain Medicine ; Predictive Value of Tests ; Prognosis ; Rehabilitation Medicine ; Retrospective Studies ; Sarcopenia ; Sarcopenia - diagnosis ; Sarcopenia - mortality ; Sarcopenia - pathology ; Survival Analysis ; Tomography, X-Ray Computed - methods</subject><ispartof>Supportive care in cancer, 2020, Vol.28 (1), p.389-394</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019</rights><rights>COPYRIGHT 2020 Springer</rights><rights>Supportive Care in Cancer is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-8b0caf46661826624190bed7c3996dd41b1e431f68837ebb0ccd6c95bef952ff3</citedby><cites>FETCH-LOGICAL-c442t-8b0caf46661826624190bed7c3996dd41b1e431f68837ebb0ccd6c95bef952ff3</cites><orcidid>0000-0001-7087-9899</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00520-019-04843-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00520-019-04843-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31055666$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dohzono, Sho</creatorcontrib><creatorcontrib>Sasaoka, Ryuichi</creatorcontrib><creatorcontrib>Takamatsu, Kiyohito</creatorcontrib><creatorcontrib>Hoshino, Masatoshi</creatorcontrib><creatorcontrib>Nakamura, Hiroaki</creatorcontrib><title>Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><addtitle>Support Care Cancer</addtitle><description>Purpose
Low skeletal muscle mass has been associated with poor prognosis in patients with advanced lung cancer. However, little is known about the relationship between skeletal muscle mass and overall survival in patients with bone metastases from lung cancer. The objective of the present study was to evaluate the prognostic value of low trunk muscle mass in predicting overall survival in these patients.
Methods
The data from 198 patients who were diagnosed with bone metastases from lung cancer from April 2009 to May 2017 were retrospectively reviewed. The areas of the psoas and paravertebral muscles were measured at the level of the third lumbar vertebra on computed tomography scans taken at the time nearest to the diagnosis of bone metastasis. Muscle area was evaluated for male and female cohorts separately using different cutoff points. Cox proportional hazards analysis was performed to evaluate the factors independently associated with overall survival.
Results
The overall survival of patients in the lowest quartile for psoas muscle area or paravertebral muscle area was significantly shorter than that of patients above the 25th percentile for muscle area (
p
< 0.001). Multivariate analyses showed that paravertebral muscle mass (hazard ratio, 1.73; 95% confidence interval, 1.17–2.56;
p
= 0.006), epidermal growth factor receptor-targeted therapy, and performance status were independent prognostic factors.
Conclusions
Low paravertebral muscle mass was associated with shorter survival, independently of known prognostic factors.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Bone cancer</subject><subject>Bone Neoplasms - diagnosis</subject><subject>Bone Neoplasms - mortality</subject><subject>Bone Neoplasms - secondary</subject><subject>Cancer</subject><subject>Cancer patients</subject><subject>Carcinoma, Non-Small-Cell Lung - diagnosis</subject><subject>Carcinoma, Non-Small-Cell Lung - mortality</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>CT imaging</subject><subject>Female</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Lumbar Vertebrae - diagnostic imaging</subject><subject>Lumbar Vertebrae - pathology</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - diagnosis</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - pathology</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Muscle, Skeletal - diagnostic imaging</subject><subject>Muscle, Skeletal - pathology</subject><subject>Muscles</subject><subject>Musculoskeletal system</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Oncology, Experimental</subject><subject>Original Article</subject><subject>Pain Medicine</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Rehabilitation Medicine</subject><subject>Retrospective Studies</subject><subject>Sarcopenia</subject><subject>Sarcopenia - diagnosis</subject><subject>Sarcopenia - mortality</subject><subject>Sarcopenia - pathology</subject><subject>Survival Analysis</subject><subject>Tomography, X-Ray Computed - methods</subject><issn>0941-4355</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kU9rFTEUxYMo9ln9Ai4k4MbN1Js_k5ksS9EqPHCj65DJ3DxTZpLXZMbSb2_qtBZFJIFA7u-ce5NDyGsGZwyge18AWg4NMN2A7KVo9BOyY1KIphNCPyU70JI1UrTtCXlRyhUA67qWPycngkHbKqV25HqfbujRZvsD84JDthOd1-ImpLMthYZYi0vAuBR6E5bvdEixlnCxpW4s1Oc002mNB-psdJhpKLQKkwt2wXHTHFPK9JjTIaYSykvyzNup4Kv785R8-_jh68WnZv_l8vPF-b5xUvKl6Qdw1ss6JOu5UlwyDQOOnRNaq3GUbGAoBfOq70WHQ6XdqJxuB_S65d6LU_Ju862dr1csi5lDcThNNmJai-FccAYdMKjo27_Qq7TmWKerFNM9F1KLR-pgJzQh-rRk6-5MzbkCpXXfMlWps39QdY04B1d_z4d6_4eAbwKXUykZvTnmMNt8axiYu5zNlrOpOZtfORtdRW_uJ16HGcffkodgKyA2oNRSPGB-fNJ_bH8CUcuyrg</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Dohzono, Sho</creator><creator>Sasaoka, Ryuichi</creator><creator>Takamatsu, Kiyohito</creator><creator>Hoshino, Masatoshi</creator><creator>Nakamura, Hiroaki</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7087-9899</orcidid></search><sort><creationdate>2020</creationdate><title>Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis</title><author>Dohzono, Sho ; Sasaoka, Ryuichi ; Takamatsu, Kiyohito ; Hoshino, Masatoshi ; Nakamura, Hiroaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-8b0caf46661826624190bed7c3996dd41b1e431f68837ebb0ccd6c95bef952ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Bone cancer</topic><topic>Bone Neoplasms - diagnosis</topic><topic>Bone Neoplasms - mortality</topic><topic>Bone Neoplasms - secondary</topic><topic>Cancer</topic><topic>Cancer patients</topic><topic>Carcinoma, Non-Small-Cell Lung - diagnosis</topic><topic>Carcinoma, Non-Small-Cell Lung - mortality</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>CT imaging</topic><topic>Female</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Lumbar Vertebrae - diagnostic imaging</topic><topic>Lumbar Vertebrae - pathology</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - diagnosis</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - pathology</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Muscle, Skeletal - diagnostic imaging</topic><topic>Muscle, Skeletal - pathology</topic><topic>Muscles</topic><topic>Musculoskeletal system</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Oncology, Experimental</topic><topic>Original Article</topic><topic>Pain Medicine</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Rehabilitation Medicine</topic><topic>Retrospective Studies</topic><topic>Sarcopenia</topic><topic>Sarcopenia - diagnosis</topic><topic>Sarcopenia - mortality</topic><topic>Sarcopenia - pathology</topic><topic>Survival Analysis</topic><topic>Tomography, X-Ray Computed - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dohzono, Sho</creatorcontrib><creatorcontrib>Sasaoka, Ryuichi</creatorcontrib><creatorcontrib>Takamatsu, Kiyohito</creatorcontrib><creatorcontrib>Hoshino, Masatoshi</creatorcontrib><creatorcontrib>Nakamura, Hiroaki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dohzono, Sho</au><au>Sasaoka, Ryuichi</au><au>Takamatsu, Kiyohito</au><au>Hoshino, Masatoshi</au><au>Nakamura, Hiroaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis</atitle><jtitle>Supportive care in cancer</jtitle><stitle>Support Care Cancer</stitle><addtitle>Support Care Cancer</addtitle><date>2020</date><risdate>2020</risdate><volume>28</volume><issue>1</issue><spage>389</spage><epage>394</epage><pages>389-394</pages><issn>0941-4355</issn><eissn>1433-7339</eissn><abstract>Purpose
Low skeletal muscle mass has been associated with poor prognosis in patients with advanced lung cancer. However, little is known about the relationship between skeletal muscle mass and overall survival in patients with bone metastases from lung cancer. The objective of the present study was to evaluate the prognostic value of low trunk muscle mass in predicting overall survival in these patients.
Methods
The data from 198 patients who were diagnosed with bone metastases from lung cancer from April 2009 to May 2017 were retrospectively reviewed. The areas of the psoas and paravertebral muscles were measured at the level of the third lumbar vertebra on computed tomography scans taken at the time nearest to the diagnosis of bone metastasis. Muscle area was evaluated for male and female cohorts separately using different cutoff points. Cox proportional hazards analysis was performed to evaluate the factors independently associated with overall survival.
Results
The overall survival of patients in the lowest quartile for psoas muscle area or paravertebral muscle area was significantly shorter than that of patients above the 25th percentile for muscle area (
p
< 0.001). Multivariate analyses showed that paravertebral muscle mass (hazard ratio, 1.73; 95% confidence interval, 1.17–2.56;
p
= 0.006), epidermal growth factor receptor-targeted therapy, and performance status were independent prognostic factors.
Conclusions
Low paravertebral muscle mass was associated with shorter survival, independently of known prognostic factors.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>31055666</pmid><doi>10.1007/s00520-019-04843-9</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-7087-9899</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0941-4355 |
| ispartof | Supportive care in cancer, 2020, Vol.28 (1), p.389-394 |
| issn | 0941-4355 1433-7339 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2232107010 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Adult Aged Aged, 80 and over Bone cancer Bone Neoplasms - diagnosis Bone Neoplasms - mortality Bone Neoplasms - secondary Cancer Cancer patients Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology CT imaging Female Health aspects Humans Lumbar Vertebrae - diagnostic imaging Lumbar Vertebrae - pathology Lung cancer Lung Neoplasms - diagnosis Lung Neoplasms - mortality Lung Neoplasms - pathology Male Medical prognosis Medicine Medicine & Public Health Metastasis Middle Aged Muscle, Skeletal - diagnostic imaging Muscle, Skeletal - pathology Muscles Musculoskeletal system Nursing Nursing Research Oncology Oncology, Experimental Original Article Pain Medicine Predictive Value of Tests Prognosis Rehabilitation Medicine Retrospective Studies Sarcopenia Sarcopenia - diagnosis Sarcopenia - mortality Sarcopenia - pathology Survival Analysis Tomography, X-Ray Computed - methods |
| title | Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T02%3A35%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20paravertebral%20muscle%20mass%20in%20patients%20with%20bone%20metastases%20from%20lung%20cancer%20is%20associated%20with%20poor%20prognosis&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=Dohzono,%20Sho&rft.date=2020&rft.volume=28&rft.issue=1&rft.spage=389&rft.epage=394&rft.pages=389-394&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-019-04843-9&rft_dat=%3Cgale_proqu%3EA606998516%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2219823493&rft_id=info:pmid/31055666&rft_galeid=A606998516&rfr_iscdi=true |